Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Non-Cytotoxic Agent

A pharmacologic substance that does not directly kill cells, but instead affects cellular transport and metabolic functions to ultimately produce… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract This study evaluated the cytotoxicity and antimicrobial activity of analogs of cationic peptides against microorganisms… Expand
Is this relevant?
Review
2017
Review
2017
Background Phase III randomized controlled trials (RCTs) are the cornerstone of evidence-based oncology. However, there is no… Expand
  • figure 1
  • table 1
  • table 2
  • table 4
  • table 5
Is this relevant?
Review
2016
Review
2016
Abstract In murine models, overexpression of the MET receptor transgene induces tumors with human basal gene expression… Expand
  • table 1
  • table 3
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Review
2014
Review
2014
BackgroundThe majority of patients with chondrosarcoma of bone have an excellent overall survival after local therapy. However… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
Abstract 1. Upamostat (Mesupron®) is a new small molecule serine protease inhibitor. The drug candidate was developed to inhibit… Expand
Is this relevant?
2008
2008
Dendritic cells (DCs) are important in HIV-1 transmission; DCs capture invading HIV-1 through the interaction of the gp120… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1995
1995
Cyclopentenyl uracil, a non-cytotoxic inhibitor of uridine kinase, was found to effectively block the salvage of circulating… Expand
Is this relevant?
1994
1994
Several inhibitors of the arachidonic acid-metabolizing enzyme, 5-lipoxygenase reduce proliferation of hematopoietic and non… Expand
Is this relevant?
1993
1993
Biochemical modulation involves the use of one drug (modulating agent; modulator) to change the pharmacokinetics and/or… Expand
Is this relevant?
1990
1990
Recurrent cancers (Devita, 1983; Goldie and Coldman, 1984) and metasta-tic disease (Fidler, 1978; Tanigawa et al, 1984) often… Expand
Is this relevant?